Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways. - Wikidata - awgldk - TriplyDB

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.

http://www.wikidata.org/entity/Q44822086

about

Chemotherapeutic sensitization of leptomycin B resistant lung cancer cells by pretreatment with doxorubicin Hydroxyl radical mediates cisplatin-induced apoptosis in human hair follicle dermal papilla cells and keratinocytes through Bcl-2-dependent mechanism Mitochondrial superoxide mediates doxorubicin-induced keratinocyte apoptosis through oxidative modification of ERK and Bcl-2 ubiquitination Fatty acid amide hydrolase is a key regulator of endocannabinoid-induced myocardial tissue injury G-actin guides p53 nuclear transport: potential contribution of monomeric actin in altered localization of mutant p53.Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer Cellular levels of oxidative stress affect the response of cervical cancer cells to chemotherapeutic agents A switching mechanism in doxorubicin bioactivation can be exploited to control doxorubicin toxicity Quercetin potentiates doxorubicin mediated antitumor effects against liver cancer through p53/Bcl-xl An increase in reactive oxygen species by deregulation of ARNT enhances chemotherapeutic drug-induced cancer cell death Skeletal Muscle an Active Compartment in the Sequestering and Metabolism of Doxorubicin Chemotherapy Nitric Oxide Down-Regulates Topoisomerase I and Induces Camptothecin Resistance in Human Breast MCF-7 Tumor Cells Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium Extracellular control of intracellular drug release for enhanced safety of anti-cancer chemotherapy Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2.Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography.Bioorthogonal cyclization-mediated in situ self-assembly of small-molecule probes for imaging caspase activity in vivo Advantages and application of label-free detection assays in drug screening.ROS and protein oxidation in early stages of cytotoxic drug induced apoptosis.Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1 Doxorubicin combined with celecoxib inhibits tumor growth of medullary thyroid carcinoma in xenografted mice Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment.Doxorubicin, DNA torsion, and chromatin dynamics.Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease The threonine protease activity of testes-specific protease 50 (TSP50) is essential for its function in cell proliferation.Anticancer drug-loaded multifunctional nanoparticles to enhance the chemotherapeutic efficacy in lung cancer metastasis Thymol and Carvacrol Prevent Doxorubicin-Induced Cardiotoxicity by Abrogation of Oxidative Stress, Inflammation, and Apoptosis in Rats.Peroxiredoxin II restrains DNA damage-induced death in cancer cells by positively regulating JNK-dependent DNA repair.Assembled microcapsules by doxorubicin and polysaccharide as high effective anticancer drug carriers.Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.Glutathione peroxidase-1 in health and disease: from molecular mechanisms to therapeutic opportunities tLivin displays flexibility by promoting alternative cell death mechanisms A Novobiocin Derivative, XN4, Inhibits the Proliferation of Chronic Myeloid Leukemia Cells by Inducing Oxidative DNA Damage Manganese (III) meso-tetrakis N-ethylpyridinium-2-yl porphyrin acts as a pro-oxidant to inhibit electron transport chain proteins, modulate bioenergetics, and enhance the response to chemotherapy in lymphoma cells.Requirement of transmembrane transport for S-nitrosocysteine-dependent modification of intracellular thiols.Members of the glutathione and ABC-transporter families are associated with clinical outcome in patients with diffuse large B-cell lymphoma.Synergistic antitumor activity of camptothecin-doxorubicin combinations and their conjugates with hyaluronic acid.MicroRNA-208a Silencing Attenuates Doxorubicin Induced Myocyte Apoptosis and Cardiac Dysfunction.Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins.

P2860

Q21134737-1D22E1C9-CE8E-46D3-98AA-2F8EA54DCF9C Q23921929-E056E5B6-3D77-403D-B3D4-6C14EC1EB348 Q23921930-73D03EEE-EEF8-45CA-9130-EFB749E3BF3D Q24595633-95D4D0E7-88CF-41D6-8E00-D55272638D40 Q27313430-DB1B4279-F5FB-4932-99D0-3BD3974649B0 Q28076041-4CC70521-A77B-4283-B470-1D336111CE5F Q28383284-5D277C30-519F-4EC9-951C-406AED5B9CD0 Q28477095-2D782851-49EE-48A0-9FB2-EE716D3741D4 Q28484294-DB9ECE52-3AF9-4936-9C24-11A10A9611FA Q28539641-8E122902-BFC5-4BF6-BE86-F1E8874315D7 Q28548399-18DE8BAF-F318-4C44-AD1A-80F8E3070384 Q28550726-98CA94E0-14D6-4645-A911-567E89A6983B Q28579647-60662DF1-ED04-4207-98B6-2180B984020B Q28829328-F058201A-123D-4C36-A3DF-20D842E58A68 Q29347119-7DD3C6D6-2EBF-41FE-A980-520B20990D4C Q30491590-362CD2C5-EF97-410D-B8D3-DD16E4832708 Q30578692-29B1AAA6-7E50-4EC3-BEA2-12AA2FC29BD3 Q30597676-67BF436A-A348-4B09-9CE0-BA06B808F2F3 Q33260811-CCE0541E-B647-4D59-A054-8C53D094E019 Q33564142-BB4D8D5A-07FB-4270-B4C0-7CE61F7EF67D Q33639024-710870A9-E9E9-4C9A-9F49-BA89AFD8A620 Q33727633-3409EADC-743A-466B-A062-A46B8314B2A7 Q34007740-49402A87-BFB0-48BA-9CFA-169603DB2E4C Q34039414-C2EB30E9-0928-4152-873C-24D7FE7F490C Q34126651-5C2B7177-D72C-4E09-A158-EC9303931CB0 Q34264487-844B1B7F-48F0-4222-AE94-A7C9A31B780F Q34308740-5C5984C3-8A74-46D2-B70D-82CE74477659 Q34494900-18FECA10-A31D-40B1-9A06-EF20AC788650 Q34624406-9F654E8F-EB1C-45CA-A2BF-DC96E54279A3 Q34647612-3AB60E5D-C84F-4B2E-B21F-A18D2B37FC87 Q35021157-D80BF534-BE14-4A33-A3DE-0EBE4661142C Q35173610-81A19C57-68C5-4807-87B9-0AE1B7785DCB Q35194005-06F3959B-58A8-497E-9AD0-14049947A52C Q35557589-6FC23189-FE34-4DD9-BDB7-304FB5F1AD2C Q35569305-324C5C6A-A697-401E-A29C-F9E1EED23CDC Q35729005-DE2AEC9D-71D4-4876-84B7-CF78709146DD Q35751025-17ECE460-6AB7-4F09-AB16-F70422C6D3DD Q35751958-9FB16B1B-E6B9-41EE-8A7D-687D5690AC25 Q35763090-FF9212FD-F6BD-42C0-839E-8D46BE9DDC42 Q35768914-473289E8-7C93-4F41-8B2C-6A8A42FFE7EC

P2860

Doxorubicin induces apoptosis in normal and tumor cells via distinctly different mechanisms. intermediacy of H(2)O(2)- and p53-dependent pathways.

http://www.wikidata.org/entity/Q44822086

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh-hant

name

Doxorubicin induces apoptosis ...... mechanisms. intermediacy of H

@nl

Doxorubicin induces apoptosis ...... )- and p53-dependent pathways.

@en

type

label

Doxorubicin induces apoptosis ...... mechanisms. intermediacy of H

@nl

Doxorubicin induces apoptosis ...... )- and p53-dependent pathways.

@en

prefLabel

Doxorubicin induces apoptosis ...... mechanisms. intermediacy of H

@nl

Doxorubicin induces apoptosis ...... )- and p53-dependent pathways.

@en

P1433

Q44822086-23CC11E6-D98F-4AF1-9DE7-4139DE719025

P1476

Q44822086-A159FD01-29F1-4AF5-AA47-1F64FD71590D

P2093

Q44822086-89B7BA47-452C-4FBB-921A-8067721CD45B

Q44822086-8DEE9EE2-FE95-463B-BEAD-0C2F936C4F5E

Q44822086-94ED297C-F4AB-4F97-8C9C-5884FD474414

Q44822086-96C3A098-C627-4BD7-852F-22F6BFC3E04C

Q44822086-B4E0ED02-9649-44AB-843F-5296DB49D8F5

Q44822086-B5F5B486-AE7E-4714-AF63-7823EE1D64F9

P2860

Q44822086-018AC0C8-5DE5-4F86-A7BF-1674E7820634

Q44822086-023C2F79-1023-4D40-96C1-D87C991E8580

Q44822086-05DB5DC3-E560-4CA6-8996-2296D262CFA3

Q44822086-27842CD3-6333-4277-ADF0-EC7C6EA82D7F

Q44822086-30F0EFFC-C763-470B-967B-DA1DF1292FE0

Q44822086-3378E887-5B97-42BC-8C57-59E1352058E7

Q44822086-3C41D8D9-62AB-4DC3-A378-1B473EB5DE0F

Q44822086-4A4FCB1E-272D-45F4-B9CC-309FCDF8AE3A

Q44822086-4A7305B4-B01F-4985-93ED-56477E3900E8

Q44822086-4F9AEE67-DEE8-41D9-A941-E4AED001E349

P304

Q44822086-A72E21D1-8D5F-4879-B607-CA7921B22D59

P31

Q44822086-8ADCBA3C-ECA9-48AB-B555-D8068973CFC0

P356

Q44822086-01AC96E3-8E87-4749-9957-99C3EF38B882

P407

Q44822086-908E381A-4836-4BD0-9A8A-C3AEEE500EFB

P433

Q44822086-A6B44899-4A91-49F3-A1BC-9AC47097354B

P478

Q44822086-9E59B0FE-E9AB-4905-BF5D-F3BC040FFB0D

P577

Q44822086-C576E1F4-A5EE-41BF-BF83-F053694539DC

P698

Q44822086-067EC646-D2A4-431E-98A4-F1B060F0E8C5

P356

P1433

Journal of Biological Chemistry

P1476

Doxorubicin induces apoptosis ...... )- and p53-dependent pathways.

@en

P2093

B Kalyanaraman

http://www.w3.org/2001/XMLSchema#string

Eugene A Konorev

http://www.w3.org/2001/XMLSchema#string

Joy Joseph

http://www.w3.org/2001/XMLSchema#string

Shasi Kalivendi

http://www.w3.org/2001/XMLSchema#string

Srigiridhar Kotamraju

http://www.w3.org/2001/XMLSchema#string

Suwei Wang

http://www.w3.org/2001/XMLSchema#string

P2860

NF-kappaB prevents cells from undergoing Cr(VI)-induced apoptosis

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

p53, the cellular gatekeeper for growth and division

Mitochondria and apoptosis

Caspases: killer proteases

p53: puzzle and paradigm

Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study.

Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-kappaB pathway and is dependent on p53 phosphorylation.

ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3.

Signaling pathways activated by daunorubicin.

P304

25535-25543

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M400944200

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

279

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15054096

http://www.w3.org/2001/XMLSchema#string